Indian Science Cruiser

Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Focus on Pheochromocytoma:A Rare Adrenomedullary Tumor


Affiliations
1 PG Department of Biotechnology, Heritage Institute of Technology, Kolkata, West Bengal, India
2 UG & PG Dept of Zoology, Midnapore College, Midnapore – 721101, India
     

   Subscribe/Renew Journal


The present introspective article focuses on Pheochromocytoma- a rare type of tumor related to the endocrine gland Adrenal; - specifically the chromaffin cells of adrenal medulla. The morpho – histology, types, etiology (which includes molecular and genetic causes) and classification of the syndromes associated with Pheochromocytoma are discussed here in detail. Treatments related with this adrenomedullary tumor, which includes certain drugs and surgical interventions) are also mentioned in this communication with equal emphasis.
User
Subscription Login to verify subscription
Notifications
Font Size

  • AG Van der Mey, PD Maaswinkel-Mooy, CJ Cornelisse, PH Schmidt, JJ van de Kamp 1989. Genomic imprinting in hereditary glomus tumors: evidence for new genetic theory. Lancet.

  • : 1291–1294 2. BH Forman, E Marban, RD Kayne et al. 1979. Ectopic ACTH syndrome due to pheochromocytoma: case report and review of the literature. Yale J Biol Med. 52(2):181-9.

  • C Trampal, H Engler, C Juhlin et al. 2004. Pheochromocytomas: detection with 11C hydroxyephedrine PET. Radiology. 230:423-428.

  • CH Mayo. 1927. Paroxysmal hypertension with tumor of the retroperitoneal nerve: report of a case. 89:1047-50.

  • CM Beard, SG Sheps, LT Kurland et al. 1983. Occurrence of pheochromocytoma in Rochester, Minnesota, 1950 through 1979. Mayo Clin Proc. 58(12): 802-4.

  • EL Bravo, RW Gifford. 1984. Pheochromocytoma: diagnosis, localization and management. N Engl J Med. 311(20): 1298-303.

  • G Eisenhofer, JW Lenders, WM Linehan et al. 1999. Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2. N Engl J Med , 340(24):1872-9.

  • G Eisenhofer., B. Rundqvist, A. Aneman, P. Friberg, N. A. Dakak, I.J. Kopin, M-C. Jacobs and J.W.M. Lenders. 1995. Regional release and removal of catecholamines and extraneuronal metabolism to metanephrines. Journal of Clinical Endocrinology and Metabolism. 80: 3009-3017.

  • HP Neumann, DP Berger, G Sigmund et al. 1993. Pheochromocytomas, multiple endocrine neoplasia type 2, & von Hippel-Lindau disease. N Engl J Med. 329(21):1531-8.

  • J Mukherjee. 1997. Pheochromocytoma: effect of nonionic contrast medium in CT on circulating catecholamine levels. Radiology. 202(1); 227-31.

  • J Xiao, Q Zhou, Y Liu. 2002. Department of Pathology, University of Oklahoma School of Medicine, Oklahoma City, Oklahoma, USA. 69 (1):104-9.

  • JW Lenders, G Eisenhofer, M Mannelli et al. 2005. Phaeochromocytoma. Lancet. 366(9486):665-75.

  • JW Lenders, HR Keiser, DS Goldstein et al. 1995. Plasma metanephrines in the diagnosis of pheochromocytoma. Ann Intern Med. 123(2):101-9.

  • MM Walther, J Herring, E Enquist, HR Keiser. 1999. Linehan: von Recklinghausen’s disease and pheochromocytomas. J Urol. 162: 1582–1586.

  • P. Riberio. D. Pigeon and S. Kaufman. 1991. Hydroxylation of phenylalanine and tyrosine by tyrosine hydroxylase from cultured pheochromocytoma cells. J. Biol. Chem. 266: 16207-16211.

  • RR Lonser, GM Glenn, M Walther, EY Chew, SK Libutti, WM Linehan. 2003, Old.eld EH: von HippelLindau disease. Lancet; 361: 2059–2067.

  • RW Gifford, WF Kvale, FT Maher. 1964. Clinical features, diagnosis and treatment of pheochromocytoma: A review of 76 cases. Mayo Clin Proc. 39:281-302.

  • S Egawa, H Futami, K Takasaki, M Iihara, T Okamoto, M Kanbe, T Ohi, Y Saio, A Miyauchi, Y Takiyama et al. 1998. Genotypephenotype correlation of patients with multiple endocrine neoplasia type 2 in Japan. Jpn J Clin Oncol . 28: 590–596

  • S.W. Carmichael, and S.L. Stoddard. 1992 in the Adrenal Medlula, 1989-1991, The Telford Press, Inc., New Jersey, USA.

  • SR Cruz, JA Colwell. 1972. Pheochromocytoma and ileus. JAMA. 219(8):1050-1.

  • T Noshiro, K Shimizu, T Watanabe, H Akama, S Shibukawa, W Miura, S Ito, Y Miura. 2000. Changes in clinical features and longterm prognosis in patients with pheochromocytoma. Am J Hypertens. 13: 35–43.

  • TH Lee. 2002. Best Cases from the AFIP, Cystic Pheochromocytoma. Radiographics. 22: 935-940.


Abstract Views: 228

PDF Views: 3




  • Focus on Pheochromocytoma:A Rare Adrenomedullary Tumor

Abstract Views: 228  |  PDF Views: 3

Authors

Riju Ghosh
PG Department of Biotechnology, Heritage Institute of Technology, Kolkata, West Bengal, India
Subho Ghosh
UG & PG Dept of Zoology, Midnapore College, Midnapore – 721101, India

Abstract


The present introspective article focuses on Pheochromocytoma- a rare type of tumor related to the endocrine gland Adrenal; - specifically the chromaffin cells of adrenal medulla. The morpho – histology, types, etiology (which includes molecular and genetic causes) and classification of the syndromes associated with Pheochromocytoma are discussed here in detail. Treatments related with this adrenomedullary tumor, which includes certain drugs and surgical interventions) are also mentioned in this communication with equal emphasis.

References





DOI: https://doi.org/10.24906/isc%2F2018%2Fv32%2Fi2%2F174867